Photo from wikipedia
Imaging tools that allow quantification of Parkinson's disease (PD) progression could facilitate the development of disease‐modifying therapies. Cross‐sectional studies have shown presynaptic terminal damage in PD patients, but longitudinal data… Click to show full abstract
Imaging tools that allow quantification of Parkinson's disease (PD) progression could facilitate the development of disease‐modifying therapies. Cross‐sectional studies have shown presynaptic terminal damage in PD patients, but longitudinal data are limited.
Keywords:
longitudinal positron;
positron emission;
disease;
parkinson disease;
emission tomography;
tomography imaging
Journal Title: Movement Disorders
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Movement Disorders
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!